Cutler Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,000
Closed -$9K 2747
2023
Q4
$9K Buy
+3,000
New +$110K ﹤0.01% 2448
2022
Q2
Sell
-18,200
Closed -$36K 5217
2022
Q1
$36K Buy
18,200
+10,700
+143% +$655K ﹤0.01% 2532
2021
Q4
$2K Buy
+7,500
New +$391K ﹤0.01% 4728
2020
Q4
Sell
-300
Closed -$1K 5049
2020
Q3
$1K Buy
+300
New +$50K ﹤0.01% 4331
2020
Q2
Sell
-5,200
Closed -$15K 4551
2020
Q1
$15K Buy
5,200
+4,800
+1,200% +$1.03M ﹤0.01% 2484
2019
Q4
$40K Hold
400
﹤0.01% 1775
2019
Q3
$19K Buy
400
+300
+300% +$49.2K ﹤0.01% 2210
2019
Q2
$1K Sell
100
-4,900
-98% -$581K ﹤0.01% 3850
2019
Q1
$75K Buy
+5,000
New +$504K 0.01% 1172
2018
Q4
Sell
-2,000
Closed -$22K 4163
2018
Q3
$22K Sell
2,000
-2,100
-51% -$222K ﹤0.01% 2172
2018
Q2
$7K Sell
4,100
-4,300
-51% -$417K ﹤0.01% 2897
2018
Q1
$25K Buy
8,400
+6,300
+300% +$679K ﹤0.01% 2124
2017
Q4
$6K Buy
2,100
+1,500
+250% +$142K ﹤0.01% 3481
2017
Q3
$4K Sell
600
-1,100
-65% -$96.1K ﹤0.01% 4562
2017
Q2
$7K Buy
1,700
+600
+55% +$50.5K ﹤0.01% 4514
2017
Q1
$19K Buy
+1,100
New +$79.2K ﹤0.01% 3371

Other funds holding LKFT

Cutler Group's LKFT Position: Q1 2024 in Review

Cutler Group sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2024, closing a stake of 345 shares — an estimated $12.8K sold.

Cutler Group first reported a position in LKFT in Q4 2016 and held it in 21 quarters. The position peaked at $1.81M in Q2 2021. 82 funds tracked by Wall St. Rank hold LKFT as of Q1 2024.

  • Cutler Group reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 345 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2024, an estimated $12.8K.
  • Cutler Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2016 and held it in 21 quarters.
  • Cutler Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.81M in Q2 2021.
  • 82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.